From the Department of Plastic and Reconstructive Surgery, Zhongshan Hospital, Fudan University, Shanghai, China.
Ann Plast Surg. 2024 Aug 1;93(2S Suppl 1):S86-S88. doi: 10.1097/SAP.0000000000003929.
Axillary hyperhidrosis and bromhidrosis are common clinical diseases, affecting the patients' work and life. Negative-pressure suction-curettage is the most popular treatment now, but challenged by a new microwave-based therapy (MiraDry). We intend to compare the safety and efficiency of the 2 treatments.
A retrospective analysis of 39 female patients with both primary hyperhidrosis and bromhidrosis was conducted. Seventeen patients were treated with MiraDry, and 22 underwent negative-pressure suction-curettage. The postoperative follow-up program included sweat and odor assessments, satisfaction measurement, safety evaluation, and recurrence assessment at different time points until 12 months.
Both treatments showed a significant reduction (P < 0.05) in HDSS score and odor level at 6 and 12 months compared with the baseline. No significant difference in relative reduction was observed between the 2 groups. The satisfaction score of the microwave-based therapy group was higher than that of the negative-pressure suction-curettage group, but no statistical difference was found. The difference in the recurrence rate and complication rate between the groups did not reach significance.
Microwave-based therapy is a noninvasive treatment with durable effects, low risks, shorter downtime, good appearance, and high satisfaction for axillary hyperhidrosis and bromhidrosis.
腋下多汗症和腋臭是常见的临床疾病，影响患者的工作和生活。目前，负压抽吸刮除术是最受欢迎的治疗方法，但受到一种新的微波治疗（MiraDry）的挑战。我们旨在比较这两种治疗方法的安全性和有效性。
对 39 名患有原发性多汗症和腋臭的女性患者进行回顾性分析。17 名患者接受了 MiraDry 治疗，22 名患者接受了负压抽吸刮除术。术后随访计划包括在不同时间点评估出汗和气味、满意度测量、安全性评估和复发评估，直到 12 个月。
两种治疗方法在 6 个月和 12 个月时与基线相比，HDSS 评分和气味水平均显著降低（P<0.05）。两组之间相对减少率没有显著差异。微波治疗组的满意度评分高于负压抽吸刮除组，但无统计学差异。两组间复发率和并发症率的差异无统计学意义。
微波治疗是一种非侵入性治疗方法，具有持久的效果、低风险、较短的停机时间、良好的外观和对腋下多汗症和腋臭的高满意度。
